Blood Bank Specimen Collection: Type and Crossmatch Requirements

Blood bank specimens carry the highest stakes of any tube you will ever draw. A mislabeled type and crossmatch sample can lead to an ABO-incompatible transfusion, and an ABO-incompatible transfusion can kill a patient within minutes. That is not a worst-case scare story. It is the reason every step of blood bank collection is governed by stricter rules than any other lab order. Patient identification, tube selection, labeling, documentation, and chain of custody all tighten when the order says type and screen or type and crossmatch.

If you only remember one thing from this article, remember this: the lab cannot fix a labeling error at the bench. They cannot tell whose blood is in the tube once it leaves the bedside. The phlebotomist is the first and last defense against a wrong blood in tube event. Everything that follows in this article is built around that fact.

Why the Rules Are Stricter

Routine chemistry and hematology tubes can be repeated. If a CBC hemolyzes, the lab calls for a redraw and the patient gets a second stick. Annoying, but recoverable. Blood bank is different. The danger is not a wrong number on a report. The danger is a unit of donor blood being matched against the wrong patient sample, then transfused into someone whose immune system will attack it.

Group A patients have anti-B antibodies in their plasma. Group B patients have anti-A. Group O patients have both. Transfuse the wrong type and those antibodies bind donor red cells, the cells lyse, complement activates, and the patient goes into a hemolytic transfusion reaction. Fever, chills, back pain, hypotension, kidney failure, disseminated intravascular coagulation. Sometimes within the first 50 mL of the unit. The lab can run a flawless crossmatch on a sample that came from the wrong patient and the result is still a fatal mismatch, because the test answered a question about the wrong person.

That is why blood bank collection has its own dedicated workflow at almost every facility. Different tube. Different ID procedure. Sometimes a different wristband. Often a separate label. Two-person verification at some hospitals. The rules are not bureaucratic. They are the only thing standing between a routine draw and a sentinel event.

Tube Selection

The tube most commonly used for blood bank testing is the pink top, which contains EDTA (ethylenediaminetetraacetic acid) at the same concentration as a lavender top. The pink color is the signal. It tells the blood bank tech that this tube was drawn under blood bank protocols, not the standard hematology workflow.

Some facilities still use lavender EDTA tubes for blood bank testing, but the trend industry-wide is toward dedicated pink tops because the visual distinction reduces handling errors. A pink tube on the rack stands out. A lavender mixed in with the CBC tubes does not. Other facilities use a specially branded blood bank tube with an attached perforated label that becomes the chain-of-custody record.

EDTA is the additive of choice for blood bank work because it preserves red cell membrane antigens for testing. Serum tubes do not work for blood bank because clotting consumes complement and alters cell-bound antibodies. Heparin can interfere with antibody detection methods. EDTA freezes the sample at the moment of collection, which is exactly what the blood bank tech needs.

Always check your facility protocol before the draw. The pink top is the default, but local policy is the rule. If you grab the wrong color, the lab will reject the specimen and the patient gets stuck again.

Minimum Fill

Blood bank EDTA tubes must be filled to the indicated mark. The 9:1 ratio that matters for citrate tubes does not apply to EDTA the same way, but underfilled EDTA tubes can give skewed results in some automated analyzers and the blood bank may reject the specimen. Fill until the vacuum stops. If the tube does not draw, change tubes and document.

Patient Identification: Three Identifiers Plus Armband

Standard venipuncture identification uses two patient identifiers (typically full name and date of birth). Blood bank collection raises the bar to three identifiers in most facilities, and the third is almost always the medical record number (MRN).

The required steps at the bedside:

1. Ask the patient to state their full name and date of birth. Do not say "Are you John Smith?" Patients on medications, in pain, or just polite will say yes to almost anything. Open-ended question only. The patient says it. You verify.
2. Compare the spoken name and DOB to the wristband. Letter for letter. Number for number. Middle initials matter. A John A. Smith is not a John B. Smith.
3. Compare the wristband to the requisition or the order in the system. Name, DOB, and MRN must all match.
4. Verify the wristband is on the patient. Not taped to the bed rail. Not sitting on the bedside table. On the wrist, attached, with the patient.

If the patient is unable to state their name (unconscious, intubated, pediatric, dementia), the wristband becomes the primary identifier and a witness identification by a nurse or family member at the bedside is required. Document the witness in the chart.

Many hospitals require a two-person verification for blood bank collections. A second licensed staff member, often the nurse, comes to the bedside and independently verifies the patient identity at the moment of draw. Both staff members sign or scan into the documentation. This is standard at most academic medical centers and required by Joint Commission for high-risk collections at many institutions.

Blood Bank ID Bands and Typenex Systems

Many hospitals add a separate blood bank wristband at the time of the type and screen draw. The most common system is Typenex, but other proprietary systems exist. The structure is the same.

The blood bank ID band has a unique identifier printed on it, often a six-digit alphanumeric code or a barcode. That same code is written on the specimen label or attached as a tear-off tag. When a unit of blood is later issued for transfusion, the unit carries a tag with that same blood bank ID. At the bedside, the transfusing nurse matches the code on the unit to the code on the patient wristband. If they do not match, the unit does not get transfused. Period.

This system is sometimes called a BBID band, a Typenex band, or a transfusion verification band. The phlebotomist places the band at the time of the original blood bank draw and is responsible for verifying the band is properly applied, the code is legible, and the matching tag is on the specimen tube.

If a patient already has a blood bank band from a recent admission and it is still active, do not place a second band. Document the existing band number on the new specimen. If the band is missing, illegible, or expired, the standing crossmatch is invalid and a fresh sample is required.

Labeling at the Bedside

Labels go on the tube at the bedside. Before the patient is left. Before any other tubes are put away. Before you walk out of the room.

Required label elements for a blood bank tube:

• Patient full name, exactly as on the wristband, including middle initial if present
• Date of birth, in the format used by your facility (be consistent)
• Medical record number
• Date and time of collection, not the time the order was placed
• Phlebotomist initials or full ID, depending on facility policy. Many require a full employee ID, not just initials, for blood bank.
• Blood bank ID number (Typenex code or equivalent), if your facility uses a separate banding system

Pre-printed labels generated from the lab system are acceptable as long as they are applied at the bedside and verified against the wristband before application. Labels are never applied before the draw. Pre-labeling is a sentinel-event-grade error in blood bank work.

If any element on the label is wrong, the entire specimen is rejected. Cross-outs and corrections are not allowed. The blood bank cannot accept an altered label because it cannot tell whether the alteration was made by the original collector or by someone else later. Wrong label = redraw.

Wrong Blood in Tube (WBIT)

Wrong blood in tube is exactly what it sounds like. The label says one patient. The blood inside is from a different patient. The lab tests the contents and reports a result that gets attached to the wrong chart. In blood bank, that means a unit of blood gets matched against the wrong person.

WBIT is tracked nationally as a patient safety event. The Joint Commission, AABB, and CAP all monitor WBIT rates as a quality indicator. The College of American Pathologists Q-Probes studies have estimated WBIT rates in the range of 1 in 1,000 to 1 in 2,000 blood bank specimens at hospitals without strict protocols. With dedicated blood bank ID systems, two-person verification, and rigorous bedside labeling, that rate drops by an order of magnitude.

WBIT happens through a small number of failure patterns:

• Mislabeling at the bedside. Phlebotomist draws patient A, picks up the wrong label set, applies labels for patient B.
• Pre-labeling. Tubes labeled before the draw. Phlebotomist gets pulled to a different room, draws the wrong patient, and the labels were already on.
• Specimen switching. Two patients drawn in sequence, tubes get mixed up between rooms. Especially common with hand-carried specimens.
• Wrong patient identified. Wristband not checked, patient unable to state name, no witness verification, draw proceeds on the wrong person entirely.

The fixes are the rules above. Three identifiers, wristband check, bedside labeling, dedicated blood bank ID system, and never pre-labeling. Every WBIT event is a failure of one or more of those steps.

ABO and Rh Compatibility

The ABO system has four blood types based on which antigens are present on red cell membranes:

• Type A: A antigen on red cells, anti-B antibody in plasma
• Type B: B antigen on red cells, anti-A antibody in plasma
• Type AB: A and B antigens on red cells, no antibodies in plasma
• Type O: No A or B antigens on red cells, both anti-A and anti-B antibodies in plasma

The Rh system adds a separate antigen, the Rh factor (most importantly the D antigen). Rh positive means the D antigen is present. Rh negative means it is absent. About 85 percent of the US population is Rh positive.

O negative is the universal donor for red cells because O cells carry no A, B, or D antigens, so any recipient can receive them without an ABO or Rh reaction. AB positive is the universal recipient because AB plasma carries no anti-A or anti-B antibodies and the recipient is already Rh positive.

For plasma products, the rules invert. AB plasma is the universal donor for plasma because it contains no anti-A or anti-B antibodies. O plasma is the universal recipient for plasma.

Type and Screen vs Type and Crossmatch

Two related orders, often confused.

A type and screen determines the patient's ABO and Rh type and screens the patient's plasma for unexpected antibodies (antibodies to red cell antigens beyond ABO and Rh, such as Kell, Duffy, Kidd). The screen takes about 45 minutes. If the screen is negative, the lab can issue compatible units quickly when needed. Type and screen is appropriate when transfusion is possible but not certain (most surgical preps, some workups).

A type and crossmatch includes the type and screen plus a direct compatibility test between the patient's plasma and a specific unit of donor red cells. The crossmatch confirms the unit will not react in the patient. A standard crossmatch takes about an hour for negative-screen patients (immediate spin or computer crossmatch) and significantly longer if the screen is positive (full antiglobulin crossmatch with antibody identification). Type and crossmatch is ordered when transfusion is expected.

From a collection standpoint, the specimen is the same. One pink-top EDTA tube, properly labeled and identified. The order in the system tells the blood bank whether to perform a screen alone or proceed to crossmatch.

Specimen Retention

Blood bank specimens are held longer than routine tubes. Most facilities retain blood bank EDTA samples for seven days from the time of collection, sometimes longer. The retention period exists for two reasons: to allow repeat testing if a transfusion reaction is investigated, and to support same-admission crossmatches without repeated venipunctures.

If a patient is admitted Monday, has a type and screen drawn Monday, and needs a transfusion Wednesday, many facilities can issue blood from the Monday sample without redrawing. After the seven-day window expires, a fresh sample is required even if the result has not changed.

Common Errors and How to Prevent Them

Pre-labeling tubes. Never. The label goes on after the draw, at the bedside, after verifying the wristband against the label. Tubes prepped at the workstation with patient labels already applied are how WBIT events happen.

Labeling away from the bedside. Do not walk out of the room to label. Do not label in the hallway. Do not label at the nurse station. The patient must be present and identifiable when the label is applied. If you draw and walk out without labeling, the specimen is not acceptable for blood bank testing.

Failing to verify the wristband. Wristband on the wrist. Name, DOB, MRN matching the order. Patient stating their own name when able. Witness identification when not.

Failing to use the dedicated blood bank ID system. If your facility uses Typenex or another BBID band, place it at the time of draw and document the code on both the band and the tube. Skipping this step invalidates the chain of custody.

Drawing from an IV line without proper protocol. If a draw must come from an existing line, the line must be flushed and a discard volume drawn first to clear IV fluid. Most blood bank policies prohibit IV-line draws entirely for type and crossmatch. Use a fresh peripheral stick when possible.

Submitting hemolyzed or clotted specimens. Hemolysis interferes with antibody detection. Clots in an EDTA tube mean inadequate mixing. Both will cause rejection.

Practice Questions